Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Eli Lilly and Company
Age
18–any
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Are overtly healthy males or females, as determined by medical history and physical examination.
Have a body mass index (BMI) of 19 to 35 kilograms per meter squared (kg/m²) inclusive, at the time of screening.
You may not be if
Have known allergies to lasmiditan, related compounds or any components of the formulation.
Have an abnormality in the 12-lead electrocardiogram (ECG) that, in the opinion of the investigator, increases the risks associated with participating in the study.
Show evidence of active renal disease or estimated glomerular filtration rate (eGFR) less than 60 milliliter per minute (mL/min) per 1.73 m².
Show evidence of or positive serology for human immunodeficiency virus (HIV) infection, hepatitis B or C.
Are women with a positive pregnancy test or women who are lactating.
Have a clinically significant abnormality in the neurological examination.
Have a history of syncope, presyncopy, uncontrolled vertigo, postural dizziness, or at risk for falls, as judged to be clinically significant by the investigator.
Have orthostatic hypotension with or without dizziness and/or syncope at screening or Day -1 upon repeat testing, or a history of it.
Clareo Health | A Study of Lasmiditan in Healthy Participants
